Latest Ameritox Ltd. Stories
BALTIMORE, May 23, 2013 /PRNewswire/ -- Ameritox, the nation's leader in pain medication monitoring, has been selected by Progressive Medical, Inc. to become part of its Urine Drug Monitoring (UDM) network to help clients manage pharmacy costs and improve the clinical outcomes for injured workers. Progressive Medical, a leading pharmacy benefit manager in the workers' compensation industry, has used UDM in its overall medication compliance and pain management strategy for several...
BALTIMORE, April 12, 2013 /PRNewswire/ -- Ameritox, one of the nation's leaders in pain medication monitoring, announced new research today showing a correlation between positive marijuana tests and higher rates of potential prescription drug non-adherence among chronic pain medication users. The research was presented at the American Academy of Pain Medicine annual meeting in Fort Lauderdale, Florida. Over the course of one year, Ameritox studied more than a 100,000 urine samples...
BALTIMORE, Jan. 31, 2013 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions®, continues to address the prescription medication abuse crisis by educating lawmakers, physicians and chronic pain patients about the importance of ensuring that patients have access to needed medications, while keeping communities safe. Chronic pain impacts one in four Americans - it affects more people than diabetes, cardiovascular disease, stroke...
BALTIMORE, Jan. 14, 2013 /PRNewswire/ -- Ameritox(SM) announced today that it is sponsoring a series of webinars this month aimed at educating physicians about a set of Kentucky laws intended to curb prescription drug misuse and abuse. Kentucky has an on-going problem with misuse, abuse and diversion of prescription painkillers. Information released by the state's Attorney General's office late last year indicated that more than 1,000 Kentuckians are dying each year from...
BALTIMORE, Jan. 9, 2013 /PRNewswire/ -- Ameritox(®), the nation's leader in medication monitoring, has become a founding member of the Coalition for Excellence in Medication Monitoring (CEMM). The coalition, consisting of some of the nation's leading medication monitoring companies, was formed to advance clinical treatment and standards of care for patients who are prescribed opioids for chronic pain. With use of prescription opioids on the rise, it is increasingly important for...
WINSTON SALEM, N.C., Dec. 4, 2012 /PRNewswire/ -- Wake Forest University and Ameritox, Ltd. today announced that Ameritox is supporting research at Wake Forest that could break new ground in developing technologies for medication monitoring and toxicology testing. "Ameritox, the nation's leader in medication monitoring with a state-of-the-art laboratory in Greensboro, and Wake Forest University are just 25 miles apart, facilitating this cutting edge exploration," said...
BALTIMORE, Nov. 8, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in medication monitoring solutions, today announced an upcoming symposium titled "Emerging Trends in Managing Opioid Abuse and Misuse: New Recommendations and Designer Drugs," to be held in conjunction with the third annual California Society of Interventional Pain Physicians (CASIPP) meeting in Newport Beach, Calif., on Nov. 10. The symposium will feature leading pain expert Daniel Bennett, M.D., medical...
BALTIMORE, Oct. 3, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in medication monitoring solutions, today announced the launch of its newest test offering for synthetic cannabinoids (also known as "synthetic marijuana," "K2," or "Spice"), a class of designer drugs intended to mimic the effects of marijuana. Adding to its portfolio of test offerings for designer drugs, which also includes a bath salts drug test (synthetic cathinones), Ameritox's synthetic marijuana drug...
BALTIMORE, Sept. 18, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions®, today announced enhancements to its test offerings, as public health concerns about the rapid increase in oxymorphone abuse continue to escalate. Law enforcement agencies report misuse and abuse of the powerful prescription pain reliever (oxymorphone is also known by the trade name Opana®) has surged in recent years. The patented Ameritox Rx Guardian(SM) with...
BALTIMORE, Sept. 7, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions(®), today announced the presentation of a scientific poster titled "Analysis of Illicit Substance Abuse and Medication Monitoring By Payer Type" at PAINWeek, the nation's largest pain conference for frontline practitioners. Analysis of nearly two million urine drug monitoring (UDM) samples revealed that illicit substance presence varies widely by payer type...
